Obesity Prevention
Conditions
Keywords
Chrononutrition, Time-Restricted Eating, Energy Balance, Glycaemic Control
Brief summary
This study compared the metabolic response to three different eating windows (morning fast,12pm-8pm; evening fast, 8am-4pm; control, 8am-8pm).
Detailed description
Humans have evolved as a diurnal species, internally governed by the circadian system, which dictates our hormone regulation. 'Chrononutrition' is a sub-discipline which combines food timing with circadian physiology. The most popular method of time-restricted feeding in the UK is to skip breakfast. However, data from several meta-analysis have shown that skipping breakfast is associated with weight gain and insulin resistance, likely due to eating later into the evening/night and therefore, out of sync with our circadian rhythm. Recent research has shown that skipping dinner (evening fasting) has improved markers of cardio-metabolic health in clinical populations, although these are typically from longer-term studies. Despite these promising findings, it is not yet known whether these findings are population specific. Therefore, the investigators are interested in examining the metabolic response pre and post-intervention to see whether these promising findings can translate into a healthy population. Furthermore, the investigators will be monitoring subjective appetite, energy intake, and expenditure to assess whether there is any short-term adaptation to a specific feeding window.
Interventions
Participants will undertake acute evening fasting (feeding between 8am-4pm) for one day. After which they will attend the laboratory, following a 16 h fast, where baseline measures will be taken and the response to a standardised meal will take place. The participant will also have an opportunity to feed ad-libitum before they leave the laboratory.
Participants will undertake an acute morning fasting trial (feeding between 12pm-8pm). After which, participants will visit the laboratory the following day, after a 16 h fast, where baseline measures will be taken and the response to a standardised meal will take place. The participant will also have an opportunity to feed ad-libitum before they leave the laboratory.
Participants will undertake an acute standard western feeding pattern (feeding between 8am-8pm). After which, participants will visit the laboratory the following day, after a 12 h fast, where baseline measures will be taken and the response to a standardised meal will take place. The participant will also have an opportunity to feed ad-libitum before they leave the laboratory.
Sponsors
Study design
Intervention model description
The study design is a randomised, controlled, crossover design in which participants undertake three conditions in a randomised order with at least one week in between trials.
Eligibility
Inclusion criteria
* recreationally active * non-smokers * non-dieting * weight stable (self-reported for \>6 months) * were not consuming any medication known to affect appetite or physical activity
Exclusion criteria
* Smokers * \>10 hours per week physical activity * Have dieted within the past 6 months * Excessive alcohol consumption (\>14 units/week) * Use of medication or supplements that may affect hormone concentrations.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glycaemic Control | 0 hour (Pre breakfast), 1 hour, 2 hour, 3.5 hour | A metabolic assessment lasting 3.5 hours will take place following a standardised, laboratory-based meal. The investigators will be taking periodic capillary and venous blood samples to measure post-prandial glucose and insulin, which together comprise 'glycaemic control'. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Energy expenditure | Activity recorded across day 1 standardisation and day 2 (lab visit and post lab visit) | Energy expenditure will be measured via a chest-worn device (Actiheart) which combines heart rate and accelerometry to gauge calories expended. |
| Visual analogue scale for subjective ratings of appetite | 0 hour (pre-breakfast), 1 hour, 2 hour, 3 hour, 4 hour (post breakfast during lab visit) | Subjective appetite will be measured on mobile devices via a software which replicates a 100mm visual analogue scale. The scale is divided into subscales of different appetite perceptions including: hunger, fullness, desire to eat and prospective food consumption. This will be measured on a scale of 0-100 (0 - none at all) (100 - a lot). |
| Acylated Ghrelin (Appetite hormone) | 0 hour (pre breakfast), 1 hour, 2 hour, and 3 hour post breakfast | Acylated Ghrelin will be measured from the venous samples taken during the post-prandial period following the standardised meal. |
| Energy Intake | 3.5 hour following breakfast | Energy intake will be measured both during lab and outside of the laboratory when the participants are free-living. During lab, energy intake will be measured through ad-libitum feeding buffet where 20 minutes will be permitted to eat as much or as little as they desire, until 'comfortably full and satisfied', followed by post-feeding measurement of the remaining food. |
| Carbohydrate Oxidation | 0 hour (pre breakfast), 1 hour, 2 hour, 3 hour post breakfast | Investigators will be collecting expired air into Douglas bags, and measuring the VO2 and VCO2 concentration to calculate carbohydrate oxidation. |
| Fat Oxidation | 0 hour (pre breakfast), 1 hour, 2 hour, 3 hour | Investigators will be collecting expired air into Douglas bags, and measuring the VO2 and VCO2 concentration to calculate fat oxidation. |
| PYY (Appetite hormone) | 0 hour (pre-breakfast), 1 hour, 2 hour, and 3 hour post breakfast | Acylated Ghrelin will be measured from the venous samples taken during the post-prandial period following the standardised meal. |
Countries
United Kingdom